Safety and Efficacy of TACLONEX Ointment in Adolescent Patients (Aged 12 to 17 Years) With Psoriasis Vulgaris

Exclusion Criteria

• •Serious allergy, serious asthma, or serious allergic skin rash.
• •A history of sensitivity to any medication.
• •PUVA or Grenz ray therapy, UVB therapy, systemic treatment with biological therapies, corticosteroids, or other therapies with an effect on psoriasis, topical treatment with corticosteroids or vitamin D analogues, treatment with enzymatic inductors, cytochrome P450 inhibitors, hypoglycemic sulfonamides, antidepressive medications, estrogen therapy, calcium supplements or vitamin D supplements.
• •Guttate, erythrodermic, exfoliative or pustular psoriasis.
• •Viral lesions of the skin, fungal or bacterial skin infections, ulcers or wounds.
• •Severe renal insufficiency, severe hepatic disorders, disorders of calcium metabolism associated with hypercalcemia, any cardiac condition or endocrine disorder.
• •Diabetes mellitus
• •Cushing's disease or Addison's disease.